216 related articles for article (PubMed ID: 18416068)
21. Adjuvant chemotherapy in lymph node positive bladder cancer.
Gofrit ON; Stadler WM; Zorn KC; Lin S; Silvestre J; Shalhav AL; Zagaja GP; Steinberg GD
Urol Oncol; 2009; 27(2):160-4. PubMed ID: 18440835
[TBL] [Abstract][Full Text] [Related]
22. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL
BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448
[TBL] [Abstract][Full Text] [Related]
23. [Postoperative and adjuvant intravesical therapy of superficial bladder tumours. Clinical practice and applied therapeutic agents].
Lingnau A; Miller K; Steiner U; Jentzmik F; Weikert S; Schostak M
Aktuelle Urol; 2009 Sep; 40(5):307-9. PubMed ID: 19637135
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study.
Walz J; Shariat SF; Suardi N; Perrotte P; Lotan Y; Palapattu GS; Gupta A; Bastian PJ; Rogers CG; Vazina A; Amiel GE; Sagalowsky AI; Schoenberg M; Lerner SP; Karakiewicz PI
BJU Int; 2008 Jun; 101(11):1356-61. PubMed ID: 18454792
[TBL] [Abstract][Full Text] [Related]
25. New agents in intravesical chemotherapy of superficial bladder cancer.
Perabo FG; Müller SC
Scand J Urol Nephrol; 2005; 39(2):108-16. PubMed ID: 16019763
[TBL] [Abstract][Full Text] [Related]
26. Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment?
Sylvester RJ
Eur Urol; 2007 Oct; 52(4):951-3; discussion 953-4. PubMed ID: 17374437
[No Abstract] [Full Text] [Related]
27. Intravesical antineoplastic therapy following transurethral resection of bladder tumors: nursing implications from the operating room to discharge.
Washburn DJ
Clin J Oncol Nurs; 2007 Aug; 11(4):553-9. PubMed ID: 17723968
[TBL] [Abstract][Full Text] [Related]
28. [Prognosis of efficacy of organ-saving treatment of invasive bladder cancer].
Ivanov SD; Masliukova EA; Karelin MI; Iamshanov VA; Kovan'ko EG
Vopr Onkol; 2006; 52(5):565-70. PubMed ID: 17168368
[TBL] [Abstract][Full Text] [Related]
29. Intraoperative radiation therapy for bladder cancer.
Martinez A; Gunderson LL
Urol Clin North Am; 1984 Nov; 11(4):693-8. PubMed ID: 6506374
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
Jancke G; Damm O; Rosell J; Jahnson S
Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
Calabrò F; Sternberg CN
Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
[TBL] [Abstract][Full Text] [Related]
32. [Intravesical instillation with epirubicin as a prophylactic treatment for superficial bladder cancer--using two different schedules].
Segawa N; Nishida T; Takahara K; Nomi H; Azuma H; Katsuoka Y
Hinyokika Kiyo; 2008 Nov; 54(11):711-6. PubMed ID: 19068724
[TBL] [Abstract][Full Text] [Related]
33. Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
Azuma H; Yamamoto K; Inamoto T; Ibuki N; Kotake Y; Sakamoto T; Kiyama S; Ubai T; Takahara K; Segawa N; Narumi Y; Katsuoka Y
Am J Clin Oncol; 2009 Dec; 32(6):592-606. PubMed ID: 19593084
[TBL] [Abstract][Full Text] [Related]
34. Management of the first recurrence of T1G3 bladder cancer: does intravesical chemotherapy deserve a chance?
Witjes JA
Urol Oncol; 2009; 27(3):322-4. PubMed ID: 19414122
[TBL] [Abstract][Full Text] [Related]
35. The effect of intravesical formalin on the destruction and regeneration of the canine bladder.
Mulcahy JJ; Farrow GM; Furlow WL; Leary FJ
Invest Urol; 1976 Nov; 14(3):177-81. PubMed ID: 992967
[TBL] [Abstract][Full Text] [Related]
36. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
Isbarn H; Karakiewicz PI; Shariat SF; Capitanio U; Palapattu GS; Sagalowsky AI; Lotan Y; Schoenberg MP; Amiel GE; Lerner SP; Sonpavde G
J Urol; 2009 Aug; 182(2):459-65; discussion 465. PubMed ID: 19524971
[TBL] [Abstract][Full Text] [Related]
37. Side effects of perioperative intravesical treatment and treatment strategies for these side effects.
Griffin JG; Holzbeierlein J
Urol Clin North Am; 2013 May; 40(2):197-210. PubMed ID: 23540778
[TBL] [Abstract][Full Text] [Related]
38. [Prognosis for therapeutic effectiveness of radiotherapy in the combined treatment of cancer].
Ivanov SD
Vopr Onkol; 2008; 54(4):483-9. PubMed ID: 18942405
[TBL] [Abstract][Full Text] [Related]
39. [Results of using dibunol in bladder tumors].
Barsel' VA; Dul'kin LM; Demidov AT
Vopr Onkol; 1977; 23(11):50-6. PubMed ID: 339536
[TBL] [Abstract][Full Text] [Related]
40. Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.
Lin CC; Hsu CH; Cheng JC; Huang CY; Tsai YC; Hsu FM; Huang KH; Cheng AL; Pu YS
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):442-8. PubMed ID: 19307067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
